Erlotinib prolongs survival in pancreatic cancer by blocking gemcitabine-induced MAPK signals (Q43968621)
Jump to navigation
Jump to search
scientific article published in February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erlotinib prolongs survival in pancreatic cancer by blocking gemcitabine-induced MAPK signals |
scientific article published in February 2013 |
Statements
1 reference
Erlotinib prolongs survival in pancreatic cancer by blocking gemcitabine-induced MAPK signals (English)
1 reference
Kazuhiko Koike
1 reference
Harold L Moses
1 reference
Koji Miyabayashi
1 reference
Hideaki Ijichi
1 reference
Dai Mohri
1 reference
Motohisa Tada
1 reference
Keisuke Yamamoto
1 reference
Yoshinari Asaoka
1 reference
Tsuneo Ikenoue
1 reference
Keisuke Tateishi
1 reference
Yousuke Nakai
1 reference
Hiroyuki Isayama
1 reference
Yasuyuki Morishita
1 reference
Masao Omata
1 reference
1 February 2013
1 reference
1 reference
73
1 reference
7
1 reference
2221-2234
1 reference
Identifiers
1 reference
1 reference